Market Summary — Midday — 2026-09-08

Market Summary

Equities traded lower at midday on Tuesday, September 8, as escalating Middle East tensions sent crude oil higher and pressured broad risk sentiment, though losses were contained by a sharp rally in semiconductor equipment names. The Dow Jones Industrial Average led decliners, down 592.58 points (-1.11%) to 52,821.67, weighed down by steep losses in health care following Novartis’ pipeline setbacks. The S&P 500 shed 30.89 points (-0.40%) to 7,687.71, while the Nasdaq Composite was the relative outperformer, off just 37.53 points (-0.14%) to 26,490.51 as strength in chip-related names offset broader softness.

The session’s dominant narrative centered on oil, which spiked following the U.S. and Iran exchanging strikes over the weekend and a Houthi attack on a Saudi Aramco facility that reportedly wounded more than 70 people. WTI crude traded as high as $93.19/bbl intraday before settling back to $92.77 (+1.4%) by late morning. Despite the energy shock, Treasury yields stayed relatively contained, limiting the equity market fallout compared to Friday’s rate-driven selloff. Sector rotation was pronounced: Energy and Utilities each posted gains of roughly 1.1%, Real Estate also outperformed, and Information Technology managed to claw back to flat-to-positive territory (+0.1%) on the back of a 2.2% surge in the PHLX Semiconductor Index. Conversely, Health Care was the session’s worst laggard (-2.2% to -2.6% through the morning), dragged down by a roughly 9-13% collapse in Novartis (NVS) and Amgen (AMGN) following disappointing pipeline data.

Breadth remained negative on both major exchanges at midday — NYSE decliners outpaced advancers 1,594 to 1,095, while Nasdaq decliners led 2,665 to 1,904 — underscoring the narrow, tech-led nature of the market’s resilience. Investors are looking ahead to a pivotal data week, with August PPI and CPI due later this week that could shape expectations for next week’s FOMC meeting.

Market Snapshot

| Index | Level | Change | % Change |
|—|—|—|—|
| Dow Jones Industrial Average | 52,821.67 | -592.58 | -1.11% |
| S&P 500 | 7,687.71 | -30.89 | -0.40% |
| Nasdaq Composite | 26,490.51 | -37.53 | -0.14% |

Exchange Breadth (Midday):

• NYSE: Advancers 1,095 | Decliners 1,594 | Volume 264.67 mln
• Nasdaq: Advancers 1,904 | Decliners 2,665 | Volume 3.90 bln

WaveFinder Breadth Metrics:

• Primary Sentiment: Very Bullish | 4% Sentiment: Neutral | 40 SMA Sentiment: Bearish
• Primary Bulls: 1,030 | Bears: 748
• 4% Bulls: 279 | Bears: 292
• Above 20-day SMA: 50%
• Above 40-day SMA: 40.73%
• 9-Month Bulls: 44 | Bears: 28 (0% Bull Follow-Through)

Sector Performance

Ranked from strongest to weakest based on Briefing.com Industry Watch and intraday sector commentary:

1. Energy — +1.1% (leading gainer; benefiting from rising crude on Middle East escalation)
2. Utilities — +1.1% (defensive bid alongside energy strength)
3. Real Estate — Listed among session’s “Strong” sectors (specific % not disclosed)
4. Information Technology — +0.1% (lifted by 2.2% surge in PHLX Semiconductor Index)
5. Industrials — Trading lower (specific % not disclosed)
6. Materials — Trading lower (specific % not disclosed)
7. Consumer Staples — Trading lower (specific % not disclosed)
8. Consumer Discretionary — Listed among session’s “Weak” sectors (specific % not disclosed)
9. Communication Services — Listed among session’s “Weak” sectors (specific % not disclosed)
10. Financials — Listed among session’s “Weak” sectors (specific % not disclosed)
11. Health Care — -2.6% (worst performer; Novartis and Amgen weakness weighing heavily)

Note: Briefing.com confirmed a total of seven S&P 500 sectors traded lower at midday, with only Energy and Utilities holding gains wider than 0.5%.

Volatility Context (WaveFinder Sector ATR): Energy showed the most elevated and rising volatility (ATR 2.86%, rising, P53), consistent with the oil-driven price action, while Real Estate (-2.24%, falling), Utilities (-1.66%, flat), and Industrials (-1.49%, falling) showed the most volatility compression among laggard sectors.

Key Earnings & Movers

Gainers:

• Lumentum (LITE) — $987.36, +$106.10 (+12.04%) — Best-performing S&P 500 name; semiconductor equipment strength
• Intel (INTC) — $105.23, +$9.43 (+9.84%) — Standout on positive analyst commentary and reports of possible price increases
• Corning (GLW) — $169.68, +$15.38 (+9.97%) — Semiconductor equipment/optical strength
• Coherent (COHR) — $308.28, +$26.42 (+9.37%) — Semiconductor equipment rally
• GE Aerospace (GE) — $339.52, +$2.40 (+0.71%) — Agreed to acquire Consolidated Precision Products (CPP) from Warburg Pincus and Berkshire Partners for $11.75 billion; financed via $7 billion cash and ~$4.75 billion new debt; expected EPS/FCF accretive in year one; deal not expected to close until second-half 2027

Decliners:

• Amgen (AMGN) — $395.52-$396.80, down as much as -$41.72 (-9.54%) — Worst-performing S&P 500 component amid sector-wide biotech weakness tied to Novartis data
• Novartis (NVS) — $139.05, -$20.94 (-13.09%) — Triple pipeline setback (see Stock Spotlight below)

Index Additions (effective before the open, September 21): Bloom Energy (BE), Everpure (P), and Illumina (ILMN) will join the S&P 500; Everpure replaces The Trade Desk (TTD).

Stock Spotlight

Novartis (NVS): Triple Pipeline Blow Rattles Confidence

Novartis shares plunged as much as 13% (to $139.05, -$20.94) after a trio of pipeline setbacks raised fundamental questions about the company’s R&D productivity and growth trajectory. The 8,323-patient Phase III HORIZON trial showed that pelacarsen lowered Lp(a) but failed to reduce the composite risk of cardiovascular death, non-fatal MI, non-fatal stroke, or urgent coronary revascularization versus placebo — despite patients already receiving guideline-directed therapy. Separately, the ~150-patient Phase III HARBOR trial for del-desiran failed to significantly improve video hand opening time in myotonic dystrophy patients, a particularly damaging result given the drug was the centerpiece of NVS’s ~$12 billion acquisition of Avidity Biosciences and had been expected to validate that deal under CEO Vas Narasimhan. These failures compound a recent decision to pause eight of ten rapcabtagene autoleucel (rap-cel) studies following patient deaths.

Novartis maintained its 5-6% sales CAGR outlook for 2025-2030, and management pointed to positive secondary/exploratory endpoint activity plus a still-active AOC platform — including delpacibart zotadirsen under FDA Priority Review for DMD44 and two successful Phase III trials for remibrutinib in relapsing multiple sclerosis. However, Briefing.com analysts note that overcoming a failed pivotal endpoint typically requires unusually strong confirmatory evidence, and the market is treating this as a broader confidence issue rather than two isolated failures. The selloff spilled over into the wider health care sector, with Amgen (-9.54%) as the worst-performing S&P 500 component and the iShares Biotechnology ETF down 1.8%, dragging the health care sector to a sector-worst -2.6% at midday.

Bond Market & Treasuries

Treasuries held modest losses at midday after an early attempted rebound faded. As of the 11:23 ET update, the 10-year note was down 2/32 with a yield of 4.794%. Earlier in the session (10:31 ET), yields were mixed but trending higher:

• 2-year: 4.39% (+1 bp)
• 3-year: 4.46% (+1 bp)
• 5-year: 4.57% (+2 bps)
• 10-year: 4.79% (+1 bp)
• 30-year: 5.25% (unchanged)

Earlier in the morning (per Page One commentary), the 10-year had briefly spiked above 4.81% before settling back to 4.76% (down 3 bps on the day), and the 2-year eased to 4.36% (down 2 bps) — reflecting a choppy session as yields initially reacted calmly to the oil spike before drifting higher into midday. The Treasury market’s relative composure despite the oil shock was cited as a key factor limiting broader equity downside. A $58 billion 3-year Treasury note auction is scheduled for results at 13:00 ET; the prior auction produced a high yield of 4.291%, bid-to-cover of 2.71, and indirect bid of 64.2%.

USD/JPY traded at 154.25 and EUR/USD at 1.1629 as of the 11:23 ET update.

Commodities

• WTI Crude Oil: $92.77/bbl, +$1.29 (+1.4%) — off session highs of $93.19 (+1.9%) reached earlier; overnight futures had been up as much as 2.7% to $93.90. Move driven by U.S.-Iran strikes and a Houthi attack on a Saudi Aramco facility.
• Brent Crude: $98.03/bbl, +1.1% (per Page One, morning levels)
• Gold: $4,449.40/ozt, -0.6% (overnight summary)
• Copper: $6.84/lb, +2.4% (overnight summary)

Note: Average U.S. gasoline prices reportedly topped $4.00/gallon on Labor Day for the first time ever, while diesel hit a record $5.90/gallon.

Overseas Markets

Specific index-level data for Asia and Europe was not provided in today’s dataset; however, key overnight developments included:

• China: August trade surplus reached CNY809.30 billion (vs. CNY805.00 billion expected; prior CNY767.07 billion), with imports up 28.2% yr/yr and exports up 25.0% yr/yr, in line with expectations.
• Japan: Q2 GDP was revised up to +0.4% qtr/qtr (vs. +0.3% expected); Current Account surplus rose to JPY2.52 trillion (vs. JPY2.46 trillion expected).
• South Korea: Q2 GDP grew 0.6% qtr/qtr and 3.7% yr/yr, both as expected.
• Germany: July trade surplus widened to EUR21.3 billion (vs. EUR16.0 billion expected); political uncertainty rising after the AfD party won a weekend regional election in Saxony-Anhalt, doubling its prior support.
• France: July trade deficit widened to EUR6.7 billion (vs. EUR6.0 billion expected).
• ECB: Widely expected to announce a rate hike on Thursday, with markets watching for signals on a potential follow-up move in December.

Economic Data

• August NFIB Small Business Optimism Index: 98.7 (actual) vs. 99.3 (Briefing.com consensus); prior 99.8 — a miss, released at 6:00 ET
• July Consumer Credit: Scheduled for 15:00 ET release; Briefing.com consensus $11.3 billion, prior $14.2 billion (not yet reported as of this update)

Looking Ahead

• 13:00 ET Today: Results of $58 billion 3-year Treasury note auction
• 15:00 ET Today: July Consumer Credit data
• Thursday: August Producer Price Index (PPI)
• Friday (Sept 11 per Big Picture commentary): August Consumer Price Index (CPI) — viewed as the key input for FOMC rate-hike expectations
• September 15-16: FOMC meeting; per CME FedWatch Tool, market currently prices a 58.4% probability of a 25-basis-point rate hike to 3.75-4.00%
• September 21 (before the open): S&P 500 index changes take effect — Bloom Energy (BE), Everpure (P), and Illumina (ILMN) added; Everpure replaces The Trade Desk (TTD)
• Ongoing: Middle East developments (U.S.-Iran tensions, Houthi activity) remain a key swing factor for oil prices and broader risk sentiment